Vir Biotechnology, Inc. (VIR) Revenue History
Vir Biotechnology, Inc. (VIR) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2019-12-31 | $711.00K |
| 2020-12-31 | $67.25M |
| 2021-12-31 | $1.09B |
| 2022-12-31 | $1.62B |
| 2023-12-31 | $86.18M |
| 2024-12-31 | $74.20M |
| 2025-12-31 | $68.56M |
How VIR compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| TGTX | TG Therapeutics Inc. | $616.29M |
| AZTA | Azenta Inc. | $593.82M |
| ATRC | AtriCure Inc. | $534.53M |
| VCYT | Veracyte Inc. | $517.14M |
| ARVN | Arvinas Inc. | $262.60M |
These are five companies in the same sector as VIR with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Vir Biotechnology, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("VIR", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | VIR | $11.78 | +5.46% | 3.15M |
| 3 | ||||
| 4 | ||||
| 5 |